USCAP Navigating Challenging Entities in Head and Neck/Endocrine Pathology: WHO 5th Edition and Beyond 2025

USCAP Navigating Challenging Entities in Head and Neck/Endocrine Pathology: WHO 5th Edition and Beyond 2025

Regular price€80,00
/
Tax included. Shipping calculated at checkout.

  • Free Shipping on orders over 45$
  • In stock, ready to ship
  • Inventory on the way

USCAP Navigating Challenging Entities in Head and Neck/Endocrine Pathology

Original release date: January 22, 2025

USCAP Navigating Challenging Entities in Head and Neck/Endocrine Pathology: WHO 5th Edition and Beyond 2025 Head and neck pathology is challenging given the broad diversity of entities that are part of the functional (rather than simply theoretical) vocabulary at these sites.

With the beta releases of the 5th editions of both the Head and Neck and Endocrine World Health Organization (WHO) Classifications of Tumors in 2022, several new concepts and entities have arisen and still remain challenging. Furthermore, since the publication of WHO 5th edition, several provisional entities and concepts have emerged making it difficult to adapt these new changes into practice. Through this course, the participants will learn diagnostic features, practical reporting, key prognostic, and theragnostic information for a variety of new and uncommon tumor types spanning several head and neck and endocrine sites.

USCAP Navigating Challenging Entities in Head and Neck/Endocrine Pathology

This course is a collaboration between the North American Society of Head and Neck Pathology (NASHNP) and USCAP.

This course offers digital slides for each case presented

Target Audience


Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Recognize the key diagnostic features for the squamous cell carcinoma subtypes.
  • Recognize key thyroid tumor subtypes with distinctive molecular and clinical correlates.
  • Develop an algorithmic approach to key categories in the sinonasal tract, namely “small round blue cell tumor” and sinonasal glandular proliferation differential diagnosis.
  • Recognize the key diagnostic features for the squamous cell carcinoma subtypes.
Continuing Medical Education

Items Included in the Purchase of this Course

  • Salivary Gland, Sinonasal Glandular and Miscellaneous Pathology – Raja R. Seethala, MD
    Section: 2 Presentations 1 Document
  • Thyroid, Bone and Soft Tissue and Intraoperative Squamous Pathology – Nicole A. Cipriani, MD
    Section: 2 Presentations 2 Documents
  • Thyroid and Squamous Lesions – Doreen N. Palsgrove, MD
    Section: 2 Presentations 1
  • Salivary, Sinonasal Mesenchymal and Round Blue Cell Tumor Pathology – Justin A. Bishop, MD
    Section: 2 Presentations 1 Document

- Orders under 45$ will have a shipping charge of a flat rate of 15$.

-Orders over 45$ will have Free Shipping.

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Testimonials

★★★★★


“I find the taste of Moringa tea to be very refreshing and it definitely gives me a feeling of ‘wellness’. I appreciate the ethics of the company. Am looking forward to trying the cream”

Elain
★★★★★


”I love knowing that everything is 100% chemical-free and tested in Canada. I also respect the sustainable farming approach that supports both Canada and Ethiopia.”

Alycia
★★★★★

Since I drink Moringa Tea I feel so much better. My mouth was always so dry but since I drink this tea I have so much saliva I drool.

I cannot believe how much it has helped me with my breathing. I love it. I even eat all the leaves - Thank you for introducing me to this herbal tea. I'm 85 years old.

Richard Dorge
Winnipeg, MB

Recently viewed